DCRU's Robert Noveck Discusses New Anticoagulant Reversal Agent (Video)

If approved, Perosphere's PER977 would be the first drug of its kind to work with new oral anticoagulants

March 17, 2014

The DCRU's Robert Noveck, MD, PhD, discusses the unit's trial of PER977 with Perosphere's James Costin, MD.